Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(43%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
4
57%
Ph phase_1
1
14%
Ph phase_3
2
29%

Phase Distribution

1

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
4(57.1%)
Phase 3Large-scale testing
2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Active, not recruiting2
Completed2
Recruiting1
Withdrawn1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 24 (57.1%)
Phase 32 (28.6%)

Trials by Status

active_not_recruiting229%
recruiting114%
completed229%
withdrawn114%
suspended114%

Recent Activity

3 active trials
Showing 5 of 7
recruitingphase_2

Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever

NCT05190991
active_not_recruitingphase_2

Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine

NCT05092776
active_not_recruitingphase_3

Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis

NCT05673902
withdrawnphase_3

Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)

NCT05432960
suspendedphase_2

Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis

NCT05107934
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05190991Phase 2

Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever

Recruiting
NCT05092776Phase 2

Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine

Active Not Recruiting
NCT05673902Phase 3

Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis

Active Not Recruiting
NCT05432960Phase 3

Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)

Withdrawn
NCT05107934Phase 2

Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis

Suspended
NCT04692766Phase 2

Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis

Completed
NCT02667639Phase 1

Pharmacokinetics and Pharmacodynamics of RPH-104 in Healthy Subjects

Completed

All 7 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
7